Adam Davidson, CEO of Trident Royalties, discusses offtake milestones and catalysts to boost FY24. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDci Advisors Regulatory News (DCI)

Share Price Information for Dci Advisors (DCI)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 4.75
Bid: 4.50
Ask: 5.00
Change: 0.00 (0.00%)
Spread: 0.50 (11.111%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 4.75
DCI Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Results of Placing Announcement

4 Jun 2015 08:00

RNS Number : 1984P
Dolphin Capital Investors Limited
04 June 2015
 

THIS ANNOUNCEMENT AND THE INFORMATION CONTAINED HEREIN IS RESTRICTED AND IS NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN WHOLE OR IN PART, IN OR INTO THE UNITED STATES, CANADA, AUSTRALIA, JAPAN, SOUTH AFRICA, JERSEY OR ANY OTHER STATE OR JURISDICTION IN WHICH SUCH RELEASE, PUBLICATION OR DISTRIBUTION WOULD BE UNLAWFUL. PLEASE SEE THE IMPORTANT NOTICE AT THE END OF THIS ANNOUNCEMENT.

 

Dolphin Capital Investors Limited

 

4 June 2015

RESULTS OF PLACING ANNOUNCEMENT

Dolphin Capital Investors Limited ("DCI" or the "Company") is pleased to announce the results of the placing announced on 3 June 2015 (the "Placing").

A total of 219,256,609 new common shares in DCI (the "New Shares") have been placed by Liberum Capital Limited ("Liberum") and Panmure Gordon (UK) Limited ("Panmure Gordon") at a price of £0.21 per New Share (the "Issue Price"), raising gross proceeds of approximately £46 million (approximately €62.7 million at an exchange rate of £1 to €1.36217). The Placing funds are in addition to the US$14.4 million (approximately €12.3 million) of 2016 Convertible Bonds due to be converted at the Issue Price as part of the €75 million fundraising announced on 3 June 2015 (the "Conversion").

The Issue Price represents a discount of approximately 6.67 per cent. from the closing mid-market price on 3 June 2015 of £0.225. The Shares being issued pursuant to the Placing and the Conversion will represent 29 per cent. of the enlarged share capital of the Company. The Shares being issued represent approximately 41 per cent. of the issued share capital of DCI prior to the Placing and Conversion.

The Shares will be issued credited as fully paid and will rank pari passu in all respects with the existing Shares, including the right to receive all future distributions, declared, paid or made in respect of the Shares following the date of Admission.

Third Point has subscribed for 52,141,884 New Shares under the Placing. Following Admission, Third Point will be interested in 181,803,423 Shares, representing 20.2 per cent. of the enlarged issued share capital of the Company. For the purposes of the AIM Rules, the participation by Third Point (a Shareholder who owns more than 10 per cent. of the issued share capital of the Company) constitutes a related party transaction. As required by the AIM Rules, the Directors (other than Justin Rimel, who is associated with Third Point) consider, having consulted with the Nominated Adviser, Grant Thornton UK LLP, that the participation by Third Point in the Placing is fair and reasonable insofar as Shareholders are concerned.

 

2016 Convertible Bond

The Company has received irrevocable undertakings from each of Fortress, Echelon and Dolphin Capital Partners Limited that, subject to the applicable conversion price of the 2016 convertible Bonds being reduced to the US dollar equivalent of the Issue Price, Fortress, Echelon and Dolphin Capital Partners Limited will convert a total of US$14.4 million in principal value of the 2016 Convertible Bonds (in which they are respectively beneficially interested) into Shares and which will result in the issuance of a further 42,930,080 Shares (the "Bond Conversion Shares").

 

Directors' Shareholdings

Under the terms of the Conversion, Dolphin Capital Partners Limited, in which Miltos Kambourides, a Non-executive Director of the Company, has a 75 per cent. interest, will receive a total of 1,250,390 Bond Conversion Shares.

As a result of the Conversion, following Admission, Mr Kambourides will be interested in 88,025,343 Shares representing 9.7 per cent. of the enlarged issued share capital of the Company.

Mr Mark Townsend, a Non-executive Director of the Company, has subscribed for 50,000 New Shares at the Issue Price. Following Admission, Mr Townsend will be interested in 131,904 Shares representing 0.01 per cent. of the issued share capital of the Company.

 

Admission

Application has been made to the London Stock Exchange for the 262,186,689 New Shares and the Bond Conversion Shares to be admitted to trading on AIM. It is expected that Admission will become effective in respect of, and that dealings on AIM will commence in such Shares, on or around 9 June 2015. Admission is conditional upon, amongst other things, the passing of the Written Resolution.

Following Admission, the Company's enlarged issued share capital will comprise 904,626,856 Shares with voting rights in the Company. The total number of voting rights of the Company will be 904,626,856 and this figure may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in the Company, under the Disclosure and Transparency Rules.

Liberum and Panmure Gordon acted as Placing Agents in respect of the Placing.

Miltos Kambourides, Founder of Dolphin and Managing Partner of Dolphin Capital Partners, stated:

 

"We are delighted to have received such strong investor support for this oversubscribed fundraise, which we believe is a positive endorsement of the refocused strategy announced yesterday and we look forward to updating shareholders on progress going forward."

 

 

For further information please contact:

 

Dolphin Capital Partners

Miltos E. Kambourides

Pierre A. Charalambides

Katerina G. Katopis

Eleni Florou

 

 

miltos@dolphincp.com

pierre@dolphincp.com

katerina@dolphincp.com

ef@dolphincp.com

 

Panmure Gordon

(Placing Agent)

Richard Gray

Andrew Potts

 

 

 

+44 (0) 20 7886 2500

 

Liberum

(Placing Agent)

Shane Le Prevost

Richard Crawley

Neil Elliot

 

 

+44 (0) 20 3100 2000

Grant Thornton UK LLP

(Nominated Adviser)

Philip Secrett

 

+44 (0) 7383 5100

FTI Consulting, London

Richard Sunderland

Claire Turvey

 

+44 (0)20 3727 1000

dolphincapital@fticonsulting.com

 

All capitalised terms used in this announcement are, unless otherwise defined herein, defined in Appendix 9 to the Placing announcement made on 3 June 2015.

 

IMPORTANT NOTICE

This announcement does not constitute an offer to sell or the solicitation of an offer to purchase any securities in any jurisdiction in which such offer or sale would be unlawful prior to registration, exemption from registration or qualification under the securities laws of any jurisdiction. In particular, the information contained herein is not for publication or distribution, directly or indirectly, in or into Australia, Canada, New Zealand or the United States. The Company's securities have not been and will not be registered under the US Securities Act of 1933, as amended (the "Securities Act") or under any securities laws of any state or other jurisdiction of the United States, and may not be offered, sold, resold, or otherwise transferred, directly or indirectly, in or into the United States except pursuant to an exemption from, or in a transaction not subject to, the registration requirements of the Securities Act and in compliance with any applicable securities laws of any state or other jurisdiction of the United States.

The distribution of this announcement into jurisdictions other than the United Kingdom may be restricted by law, and, therefore, persons into whose possession this announcement comes should inform themselves about and observe any such restrictions.

Neither the content of the Company's website nor any website accessible by hyperlinks on the Company's website is incorporated in, or forms part of, this announcement.

Liberum and Panmure Gordon, who are regulated in the United Kingdom by the Financial Conduct Authority, are acting solely for the Company and no one else in connection with the Placing and will not regard any other person (whether or not a recipient of this announcement) as a client in relation to the Placing and will not be responsible to anyone other than the Company for providing the protections afforded to respective clients of Liberum and Panmure Gordon nor for providing advice in connection with the Placing or any other matter referred to in this announcement.

This announcement has been issued by, and is the sole responsibility of, the Company. Apart from the responsibilities and liabilities, if any, which may be imposed on Liberum and Panmure Gordon under FSMA or the regulatory regime established thereunder, none of Liberum or Panmure Gordon accepts any responsibility or liability whatsoever and makes no representation or warranty, express or implied, in relation to the contents of this announcement, including its accuracy, completeness or verification or for any other statement made or purported to be made by them, or on their behalf, in connection with the Company or the Placing. Liberum and Panmure Gordon accordingly disclaim, to the fullest extent permitted by law, all and any responsibility and liability, whether arising in tort, contract or otherwise, which they might otherwise be found to have in respect of this announcement or any such statement.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCFIMRTMBMMMMA
Date   Source Headline
29th Apr 202411:32 amRNSHolding(s) in Company
16th Apr 202412:38 pmRNSShareholder Loan & Related Party Transaction
15th Apr 20242:26 pmRNSShareholder Update
2nd Apr 20243:33 pmRNSUpdate on legal actions
28th Mar 20249:43 amRNSLegal Update
14th Mar 20242:57 pmRNSFurther Shareholder Loan and RPT
27th Feb 20242:17 pmRNSHolding(s) in Company
23rd Feb 20245:00 pmRNSHolding(s) in Company
9th Feb 20245:07 pmRNSFurther Shareholder Loan
9th Feb 20243:39 pmRNSHolding(s) in Company
27th Dec 20232:23 pmRNSGovernment Grant to the Kilada Project
15th Dec 20239:36 amRNSResult of AGM
13th Dec 20238:53 amRNSShareholder Loan
13th Dec 20238:46 amRNSUpdate on legal actions
1st Dec 20233:44 pmRNSHolding(s) in Company
22nd Nov 202312:32 pmRNSAGM Timing
21st Nov 202311:30 amRNSNotice of AGM
16th Nov 20233:31 pmRNSShareholder Loan
6th Oct 20232:17 pmRNSShareholder Loan
29th Sep 20237:00 amRNSHalf-year Report
14th Sep 202312:32 pmRNSShareholder Loans and a Related Party Transaction
7th Sep 20234:17 pmRNSHolding(s) in Company
30th Aug 202310:22 amRNSDirector/PDMR Shareholding
29th Aug 202310:07 amRNSDirector/PDMR Shareholding
21st Aug 202311:46 amRNSHolding(s) in Company
8th Aug 20239:23 amRNSDirector/PDMR Shareholding
3rd Aug 20234:35 pmRNSDirector/PDMR Shareholding
1st Aug 20234:33 pmRNSNotification of Transaction of a PCA
27th Jul 20233:14 pmRNSDirector/PDMR Shareholding
30th Jun 20231:25 pmRNSAnnual Financial Report
29th Jun 20234:50 pmRNSShareholder Loans
7th Jun 20237:00 amRNSChange of Name
26th May 20232:19 pmRNSShareholder Loans
26th May 20239:41 amRNSKilada Funding
3rd May 20234:24 pmRNSHolding(s) in Company
28th Apr 20239:41 amRNSShareholder Loans
27th Apr 20232:45 pmRNSHolding(s) in Company
19th Apr 20237:00 amRNSShareholder Loans and Related Party Transaction
18th Apr 202310:30 amRNSShareholder Update
13th Apr 20234:21 pmRNSHolding(s) in Company
13th Apr 20233:58 pmRNSHolding(s) in Company
11th Apr 20234:36 pmRNSHolding(s) in Company
11th Apr 20233:12 pmRNSFiling of Claim Form
6th Apr 20234:50 pmRNSHolding(s) in Company
5th Apr 20234:39 pmRNSNew website now live
31st Mar 20236:13 pmRNSCompany Website
20th Mar 20237:00 amRNSTermination of Inv. Manager & Removal of Director
17th Feb 20233:48 pmRNSHolding(s) in Company
13th Feb 20237:00 amRNSDirectorate Change
23rd Dec 20229:07 amRNSCompletion of disposal of interest in OOKI

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.